---
trial_id: 332
discovery_date: 2022-04-02 17:30:16.067098
date: 2022-04-02 17:30:16.067098
title: "A Phase II, Multi-center, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Pharmacodynamic Effect of Single and Multiple Oral Doses of AZD1446/ Placebo and a Single Dos..."
summary: |
  <p>EudraCT Number: 2010-018273-38<br />Sponsor Protocol Number: D1950C00011<br />Sponsor Name: AstraZeneca AB<br />Start Date: 2010-03-22<br />Medical condition: Alzheimer's Disease<br />Disease: <br />Version: 12.1<br />SOC Term: <br />Classification Code: 10001896<br />Term: Alzheimer's disease<br />Level: LLT<br /><br />Population Age: Adults, Elderly<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018273-38/FR">FR</a> (Completed)</p>
link: 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2010-018273-38'
published_date: NaT
trial_source: Clinical Trials Register Europe
relevant: 
options:
  unlisted: false
---
<p>EudraCT Number: 2010-018273-38<br />Sponsor Protocol Number: D1950C00011<br />Sponsor Name: AstraZeneca AB<br />Start Date: 2010-03-22<br />Medical condition: Alzheimer's Disease<br />Disease: <br />Version: 12.1<br />SOC Term: <br />Classification Code: 10001896<br />Term: Alzheimer's disease<br />Level: LLT<br /><br />Population Age: Adults, Elderly<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018273-38/FR">FR</a> (Completed)</p>